China National Medicines Corp Ltd (600511) — Capital Reinvestment Ratio
China National Medicines Corp Ltd (600511) has a Capital Reinvestment Ratio of 0.03x as of June 2025, meaning it reinvests 0% of its operating cash flow (CN¥382.74 Million) in capital expenditures (CN¥13.23 Million). See how leveraged is China National Medicines Corp Ltd's balance sheet to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
China National Medicines Corp Ltd Capital Reinvestment Ratio (2002–2024)
This chart tracks China National Medicines Corp Ltd's Capital Reinvestment Ratio across 22 annual periods. Check cash flow reinvestment rate of China National Medicines Corp Ltd to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for China National Medicines Corp Ltd (2002–2024)
Year-by-year Capital Reinvestment Ratio for China National Medicines Corp Ltd from 2002 to 2024. For live market cap and broader valuation context, see 600511 company net worth.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.08x | CN¥1.66 Billion | CN¥130.77 Million | ▲ +48.1% |
| 2023 | 0.05x | CN¥2.73 Billion | CN¥145.12 Million | ▼ -1.8% |
| 2022 | 0.05x | CN¥2.40 Billion | CN¥129.78 Million | ▲ +11.6% |
| 2021 | 0.05x | CN¥1.96 Billion | CN¥95.07 Million | ▼ -8.5% |
| 2020 | 0.05x | CN¥1.30 Billion | CN¥69.05 Million | ▲ +9.9% |
| 2019 | 0.05x | CN¥1.78 Billion | CN¥85.72 Million | ▼ -64.2% |
| 2018 | 0.13x | CN¥981.65 Million | CN¥132.46 Million | ▲ +97.9% |
| 2017 | 0.07x | CN¥1.07 Billion | CN¥73.25 Million | ▲ +1.1% |
| 2016 | 0.07x | CN¥591.25 Million | CN¥39.88 Million | ▼ -56.6% |
| 2015 | 0.16x | CN¥440.29 Million | CN¥68.47 Million | ▼ -77.0% |
| 2014 | 0.68x | CN¥218.94 Million | CN¥148.22 Million | ▲ +3.3% |
| 2013 | 0.66x | CN¥185.56 Million | CN¥121.66 Million | ▼ -28.2% |
| 2012 | 0.91x | CN¥185.87 Million | CN¥169.65 Million | ▲ +1105.7% |
| 2010 | 0.08x | CN¥318.21 Million | CN¥24.09 Million | ▼ -13.5% |
| 2009 | 0.09x | CN¥255.18 Million | CN¥22.33 Million | ▲ +17.2% |
| 2008 | 0.07x | CN¥217.10 Million | CN¥16.21 Million | ▼ -31.1% |
| 2007 | 0.11x | CN¥79.48 Million | CN¥8.61 Million | ▼ -44.7% |
| 2006 | 0.20x | CN¥121.50 Million | CN¥23.81 Million | ▼ -56.2% |
| 2005 | 0.45x | CN¥92.20 Million | CN¥41.24 Million | ▼ -74.7% |
| 2004 | 1.77x | CN¥49.18 Million | CN¥87.08 Million | ▼ -99.0% |
| 2003 | 172.79x | CN¥526.15K | CN¥90.92 Million | ▲ +18401.7% |
| 2002 | 0.93x | CN¥15.19 Million | CN¥14.19 Million | — |